Piramal Discovery Solutions offers a comprehensive range of Contract Research Services from our state-of-the-art research centre in India to support drug discovery activities
Piramal offers clinical development services from Phase I to Phase III for various dosage form such as Oral solids, liquids, creams, ointments, and sterile injectable
Piramal offers contract manufacturing for API, HPAPI and a wide variety of dosage forms. Our global manufacturing sites located across North America, Europe and India offer the highest standards of quality and service to the customers
Piramal is the global leader in delivering customer-centric solutions in the field of Antibody Drug Conjugates (ADCs) and other bioconjugates to global biopharmaceutical companies
Piramal’s Generic API division offers an indigenous basket of off-patent APIs for global markets. With the declining pipeline of new drugs in the pharmaceutical industry, our customers are looking for off-patent APIs with competitive cost and quality
Piramal Nutrition Solutions (PNS), division of Piramal Enterprises Limited (PEL) is one of the leading manufacturers of Straight Vitamins and Mineral premixes
We have an experienced team of over 80 scientists (with over 20 Ph.D.’s) dedicated to innovation in new product development, cost optimization, and novel route scouting projects. The R&D team develops novel/non-infringing process for APIs and is supported by a state-of-the-art, ‘best in class’, analytical research capabilities.
R & D capabilities include:
Development of environmental friendly processes
Development of chiral APIs
Ability to comply with ICH guidelines
Synthesis, Isolation and characterization of impurities
Expertise in handling pyrophoric reagent
Expertise in cryogenic reactions (-40 to -100°C)
Expertise in handling organometallic reactions
Locations
Our APIs are manufactured at US FDA approved sites across the globe- sites which have impeccable quality records: no warning letters or import alerts on any Piramal sites since inception of the company (1988 until today). On time readiness and delivery has been our strength through the combination of R&D innovation and fully integrated supply chain that levers the manufacture of intermediates in-house to help control cost and meet aggressive timelines. The API manufacturing sites are US FDA, UK MHRA, PMDA Japan, WHO GMP approved. The sites have API Regulatory submissions across the globe including e-CTD.
Thank You For Your Interest. Please Enter Your Details
Do you have a generic API development or manufacturing requirement?